Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results
Saved in:
| Title: | Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results |
|---|---|
| Authors: | Fulgent Genetics, Inc. |
| Source: | Business Wire (English). 02/27/2026. |
| Abstract: | Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its fourth quarter and full year ended December 31, 2025. [ABSTRACT FROM PUBLISHER] |
| Database: | Regional Business News |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its fourth quarter and full year ended December 31, 2025. [ABSTRACT FROM PUBLISHER] |
|---|
